Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
SHANGHAI PECHEM
00338
| (FY)Dec 31, 2025 | (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0.82%11.89M | 14.78%5.64M | 7.01%11.79M | 7.89%4.91M | 7.82%11.02M | 12.20%7.41M | 5.18%4.55M | -13.36%1.81M | 15.54%10.22M | 16.96%6.61M |
| Operating income | 0.82%11.89M | 14.78%5.64M | 7.01%11.79M | 7.89%4.91M | 7.82%11.02M | 12.20%7.41M | 5.18%4.55M | -13.36%1.81M | 15.54%10.22M | 16.96%6.61M |
| Cost of sales | -10.68%-8.9M | -6.51%-4.4M | 6.21%-8.04M | -0.24%-4.13M | 1.99%-8.57M | 3.19%-6.21M | 4.56%-4.12M | 6.95%-2.07M | -8.15%-8.74M | -16.56%-6.42M |
| Operating expenses | -10.68%-8.9M | -6.51%-4.4M | 6.21%-8.04M | -0.24%-4.13M | 1.99%-8.57M | 3.19%-6.21M | 4.56%-4.12M | 6.95%-2.07M | -8.15%-8.74M | -16.56%-6.42M |
| Gross profit | -20.27%2.99M | 58.82%1.23M | 53.20%3.76M | 81.54%777K | 65.83%2.45M | 534.92%1.2M | 6,014.29%428K | -88.57%-264K | 93.96%1.48M | 32.17%189K |
| Administrative expenses | 2.49%-3.4M | -3.17%-1.76M | -5.19%-3.49M | 7.64%-1.71M | -4.11%-3.32M | -20.57%-2.64M | -17.96%-1.85M | -1.82%-838K | 12.38%-3.18M | 5.40%-2.19M |
| Impairment and provision | 82.13%-47K | ---- | -305.47%-263K | ---- | 131.84%128K | ---- | ---- | ---- | 95.29%-402K | ---- |
| -Other impairment is provision | 82.13%-47K | ---- | -305.47%-263K | ---- | 131.84%128K | ---- | ---- | ---- | 95.09%-402K | ---- |
| Special items of operating profit | -60.67%153K | -4.21%91K | -43.05%389K | -85.58%95K | 73.79%683K | 160.22%700K | 254.30%659K | -26.19%93K | -48.89%393K | -61.46%269K |
| Operating profit | -176.14%-300K | 47.90%-434K | 843.40%394K | -9.75%-833K | 96.91%-53K | 57.34%-738K | 44.68%-759K | -20.55%-1.01M | 83.86%-1.72M | -17.53%-1.73M |
| Financing cost | 82.98%-8K | 82.35%-6K | 33.80%-47K | 2.86%-34K | -51.06%-71K | -80.00%-54K | -84.21%-35K | -55.56%-14K | -23.68%-47K | -30.43%-30K |
| Share of profits of associates | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 99.06%-1K | 183.62%97K |
| Earning before tax | -188.76%-308K | 49.25%-440K | 379.84%347K | -9.19%-867K | 92.97%-124K | 52.38%-792K | 41.66%-794K | -25.37%-1.02M | 83.64%-1.76M | -3.23%-1.66M |
| Tax | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --33K | ---- |
| After-tax profit from continuing operations | -188.76%-308K | 49.25%-440K | 379.84%347K | -9.19%-867K | 92.83%-124K | 52.38%-792K | 41.66%-794K | -25.37%-1.02M | 83.94%-1.73M | -3.23%-1.66M |
| Earning after tax | -188.76%-308K | 49.25%-440K | 379.84%347K | -9.19%-867K | 92.83%-124K | 52.38%-792K | 41.66%-794K | -25.37%-1.02M | 83.94%-1.73M | -3.23%-1.66M |
| Profit attributable to shareholders | -188.76%-308K | 49.25%-440K | 379.84%347K | -9.19%-867K | 92.83%-124K | 52.38%-792K | 41.66%-794K | -25.37%-1.02M | 83.94%-1.73M | -3.23%-1.66M |
| Basic earnings per share | -180.00%-0.0004 | 50.00%-0.0006 | 350.00%0.0005 | -9.09%-0.0012 | 91.67%-0.0002 | 56.00%-0.0011 | 47.62%-0.0011 | -27.27%-0.0014 | 85.37%-0.0024 | -13.64%-0.0025 |
| Diluted earnings per share | -180.00%-0.0004 | 50.00%-0.0006 | 350.00%0.0005 | -9.09%-0.0012 | 91.67%-0.0002 | 56.00%-0.0011 | 47.62%-0.0011 | -27.27%-0.0014 | 85.37%-0.0024 | -13.64%-0.0025 |
| Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
| Auditor | -- | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | -- | -- | National Health Accounting Firm Co., Ltd. | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.